Skip to content
Returning 2023
Menu
Home
About
About Event
Media Library
Program
2022 Full Event Guide
Partner
Partnership Opportunities
Take Part
Register Interest
Contact Us
The Story of Ruxolitinib: The First Approved Topical JAK Inhibitor for Atopic Dermatitis
Time:
10:15 am
day:
Day One
Speakers:
Jim Lee
Read more